Bartosz Hudzik: Clarifying Pulmonary Embolism Care with the New AHA/ACC Guideline
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared a post on LinkedIn about the new AHA/ACC guideline by Mark A. Creager et al, adding:
”Pulmonary embolism care is evolving — and the new AHA/ACC guideline makes that clear.
This isn’t just another update.
It reflects a broader shift from treating PE as a single acute event to managing it as a risk-stratified clinical pathway with structured follow-up.
A few takeaways that stand out:
- Risk stratification is now central to decision-making. The new classification framework helps identify which patients truly need intensive intervention — and which may be safely managed with less resource-intensive pathways.
- Therapeutic strategy continues to modernize. Direct oral anticoagulants remain preferred for most eligible patients, reinforcing the move toward safer, more streamlined anticoagulation.
- Follow-up is part of treatment. Persistent symptoms, functional limitation, and chronic thromboembolic disease are now explicitly addressed — highlighting that PE outcomes are determined long after discharge.
For clinicians, this means re-thinking workflows and escalation pathways.
For hospitals, it strengthens the case for coordinated PE response teams.
For patients, it signals more individualized and longitudinal care.
Curious how others are translating these recommendations into practice — particularly around triage pathways, outpatient management, and structured follow-up.
Cardiology and thrombosis experts across academia and clinical practice — would value your perspective on implementation challenges and opportunities”
Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Authors: Mark A. Creager, Geoffrey D. Barnes, Jay Giri, Debabrata Mukherjee, William Schuyler Jones, Allison E. Burnett, Teresa Carman, Ana I. Casanegra, Lana A. Castellucci, Sherrell M. Clark, Mary Cushman, Kerstin de Wit, Jennifer M. Eaves, Margaret C. Fang, Joshua B. Goldberg, Stanislav Henkin, Hillary Johnston-Cox, Sabeeda Kadavath, Daniella Kadian-Dodov, William Brent Keeling, Andrew J. P. Klein, Jun Li, Michael C. McDaniel, Lisa K. Moores, Gregory Piazza, Karen S. Prenger, Steven C. Pugliese, Mona Ranade, Rachel P. Rosovsky, Farla Russo, Eric A. Secemsky, Akhilesh K. Sista, Leben Tefera, Ido Weinberg, Lauren M. Westafer, Michael N. Young
Read the Full Article on Circulation
Stay updated on all scientific advances with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow